Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12333885 | 0.88 | MAPT (0.38) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL24443824 | 0.79 | PABPC1 (0.44) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL24514478 | 0.79 | PABPC1 (0.37) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL22699857 | 0.79 | MAPT (0.34) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL24443643 | 0.79 | PABPC1 (0.37) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL15037459 | 0.78 | TDP1 (0.39) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL15687380 | 0.78 | MAPT (0.37) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL10782928 | 0.75 | PABPC1 (0.41) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL15039505 | 0.74 | DNM1 (0.41) | MAPTTDP1MEN1KMT2ARAB9A | |
| SCHEMBL20288340 | 0.74 | MAPT (0.34) | MAPTTDP1MEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029428-A | Nanoenzyme-based lateral flow chromatography and device | 斯里·奇特拉·蒂鲁纳尔医学科学与技术研究所 | 2026-05-12 | — | — | CN | disclosed |
| WO-2025041169-A1 | A NANOZYME BASED LATERAL FLOW ASSAY AND DEVICE | SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY (IN) | 2025-02-27 | — | — | WO | disclosed |
| US-20210205193-A1 | TREATMENT COMPOSITION FOR DYEING | JOO, SEONG CHEOL (KR) | 2021-07-08 | — | — | US | disclosed |
| EP-3111915-B1 | CATALYSED DYE SYSTEMS | UNIV LEEDS INNOVATIONS LTD (GB) | 2017-10-04 | — | — | EP | disclosed |
| EP-3111915-A1 | CATALYSED DYE SYSTEMS | UNIVERSITY OF LEEDS (GB) | 2017-01-04 | — | — | EP | disclosed |
| EP-2448545-B1 | CATALYSED DYE SYSTEMS | UNIV LEEDS (GB) | 2016-09-07 | — | — | EP | disclosed |
| US-8535391-B2 | Catalysed dye systems | UNIVERSITY OF LEEDS (GB) | 2013-09-17 | — | — | US | disclosed |
| US-8535391-B2 | Catalysed dye systems | UNIVERSITY OF LEEDS (GB) | 2013-09-17 | — | — | US | disclosed |
| US-20120110751-A1 | Catalysed Dye Systems | UNIVERSITY OF LEEDS (GB) | 2012-05-10 | — | — | US | disclosed |
| US-20120110751-A1 | Catalysed Dye Systems | UNIVERSITY OF LEEDS (GB) | 2012-05-10 | — | — | US | disclosed |
| WO-2011000892-A2 | CATALYSED DYE SYSTEMS | UNIVERSITY OF LEEDS (GB) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210205193-A1 | TREATMENT COMPOSITION FOR DYEING | CTH, AADAT, SDHB | MAPT 1855/4885TDP1 3226/4885MEN1 1106/4885 |
| US-20120110751-A1 | Catalysed Dye Systems | FH, TYR, POLR1C | MAPT 1134/4885TDP1 1899/4885MEN1 2170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.